# OnCo record arsenic-trioxide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/arsenic-trioxide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "arsenic-trioxide" ;
  schema:name "Arsenic trioxide"@en ;
  schema:description "An ancient poison turned cure: with retinoic acid it cures more than 95% of acute promyelocytic leukaemia without conventional chemotherapy."@en ;
  schema:url <https://onco.cc/drugs/arsenic-trioxide/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Arsenic_trioxide> ;
  owl:sameAs <http://www.wikidata.org/entity/Q7739> ;
  schema:citation <https://doi.org/10.1056/NEJMoa1300874>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=arsenic%20trioxide> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "Inorganic arsenical (differentiation agent)" ;
  schema:alternateName "Trisenox" ;
  onco:approval "US 2000: Relapsed/refractory APL", "US 2018: Newly diagnosed low-risk APL with tretinoin", "EU 2002: APL" ;
  onco:related <https://onco.cc/technologies/traditional-chinese-herbal-medicine/> ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/apl/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:companies <https://onco.cc/companies/teva/> ;
  onco:terms <https://onco.cc/terms/differentiation-syndrome/> .
